-
1
-
-
72949093335
-
From pathogenesis to treatment of chronic lymphocytic leukaemia
-
Zenz T, Mertens D, Kuppers R, Dohner H, Stilgenbauer S. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 2010; 10: 37-50.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 37-50
-
-
Zenz, T.1
Mertens, D.2
Kuppers, R.3
Dohner, H.4
Stilgenbauer, S.5
-
2
-
-
79551499597
-
What is the best frontline therapy for patients with CLL and 17p deletioñ
-
Badoux X, Keating M, Wierda W. What is the best frontline therapy for patients with CLL and 17p deletioñCurr Hematol Malig Rep 2011; 6: 36-46.
-
(2011)
Curr Hematol Malig Rep
, vol.6
, pp. 36-46
-
-
Badoux, X.1
Keating, M.2
Wierda, W.3
-
3
-
-
0036275343
-
Genetics of chronic lymphocytic leukemia: Genomic aberrations and VH gene mutation status in pathogenesis and clinical course
-
the German CLL Study Group (GCLLSG)
-
Stilgenbauer SLB, Lichter P, Do hner H. the German CLL Study Group (GCLLSG). Genetics of chronic lymphocytic leukemia: Genomic aberrations and VH gene mutation status in pathogenesis and clinical course. Leukemia 2002; 16: 993-1007.
-
(2002)
Leukemia
, vol.16
, pp. 993-1007
-
-
Stilgenbauer, S.L.B.1
Lichter, P.2
Dohner, H.3
-
4
-
-
84870734255
-
Emerging role of kinase-Targeted strategies in chronic lymphocytic leukemia
-
Wiestner A. Emerging role of kinase-Targeted strategies in chronic lymphocytic leukemia. Blood 2012; 120: 4684-4691.
-
(2012)
Blood
, vol.120
, pp. 4684-4691
-
-
Wiestner, A.1
-
5
-
-
84879748062
-
Targeting btk with ibrutinib in relapsed chronic lymphocytic leukemia
-
Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA et al. Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med 2013; 369: 32-42.
-
(2013)
N Engl J Med
, vol.369
, pp. 32-42
-
-
Byrd, J.C.1
Furman, R.R.2
Coutre, S.E.3
Flinn, I.W.4
Burger, J.A.5
Blum, K.A.6
-
6
-
-
52449121246
-
Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease?
-
Caligaris-Cappio F, Ghia P. Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease? J Clin Oncol 2008; 26: 4497-4503.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4497-4503
-
-
Caligaris-Cappio, F.1
Ghia, P.2
-
7
-
-
70349562920
-
Molecular and cellular mechanisms of CLL: Novel therapeutic approaches
-
Pleyer L, Egle A, Hartmann TN, Greil R. Molecular and cellular mechanisms of CLL: Novel therapeutic approaches. Nat Rev Clin Oncol 2009; 6: 405-418.
-
(2009)
Nat Rev Clin Oncol
, vol.6
, pp. 405-418
-
-
Pleyer, L.1
Egle, A.2
Hartmann, T.N.3
Greil, R.4
-
8
-
-
0037097598
-
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-Associated genes
-
DOI 10.1182/blood.V99.12.4554
-
Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-Associated genes. Blood 2002; 99: 4554-4561. (Pubitemid 34627227)
-
(2002)
Blood
, vol.99
, Issue.12
, pp. 4554-4561
-
-
Korz, C.1
Pscherer, A.2
Banner, A.3
Mertens, D.4
Schaffner, C.5
Leupolt, E.6
Dohner, H.7
Stilgenbauer, S.8
Lichter, P.9
-
9
-
-
84866152172
-
Chronic lymphocytic leukaemia is driven by antigen-independent cell-Autonomous signalling
-
Minden MD-v Ubelhart R, Schneider D, Wossning T, Bach MP, Buchner M et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-Autonomous signalling. Nature 2012; 489: 309-312.
-
(2012)
Nature
, vol.489
, pp. 309-312
-
-
Minden, M.D.-V.1
Ubelhart, R.2
Schneider, D.3
Wossning, T.4
Bach, M.P.5
Buchner, M.6
-
10
-
-
0024556599
-
Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro
-
Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JF. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 1989; 71: 343-350. (Pubitemid 19086646)
-
(1989)
British Journal of Haematology
, vol.71
, Issue.3
, pp. 343-350
-
-
Collins, R.J.1
Verschuer, L.A.2
Harmon, B.V.3
Prentice, R.L.4
Pope, J.H.5
Kerr, J.F.R.6
-
11
-
-
0032055818
-
Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells
-
Lagneaux L, Delforge A, Bron D, De Bruyn C, Stryckmans P. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 1998; 91: 2387-2396.
-
(1998)
Blood
, vol.91
, pp. 2387-2396
-
-
Lagneaux, L.1
Delforge, A.2
Bron, D.3
De Bruyn, C.4
Stryckmans, P.5
-
12
-
-
0030048565
-
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro
-
Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand AV. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 1996; 92: 97-103. (Pubitemid 26018774)
-
(1996)
British Journal of Haematology
, vol.92
, Issue.1
, pp. 97-103
-
-
Panayiotidis, P.1
Jones, D.2
Ganeshaguru, K.3
Foroni, L.4
Hoffbrand, A.V.5
-
13
-
-
0036720390
-
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1
-
Pedersen IM, Kitada S, Leoni LM, Zapata JM, Karras JG, Tsukada N et al. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 2002; 100: 1795-1801. (Pubitemid 34925159)
-
(2002)
Blood
, vol.100
, Issue.5
, pp. 1795-1801
-
-
Pedersen, I.M.1
Kitada, S.2
Leoni, L.M.3
Zapata, J.M.4
Karras, J.G.5
Tsukada, N.6
Kipps, T.J.7
Choi, Y.S.8
Bennett, F.9
Reed, J.C.10
-
14
-
-
78549254942
-
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo
-
Seiffert M, Schulz A, Ohl S, Dohner H, Stilgenbauer S, Lichter P. Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo. Blood 2010; 116: 4223-4230.
-
(2010)
Blood
, vol.116
, pp. 4223-4230
-
-
Seiffert, M.1
Schulz, A.2
Ohl, S.3
Dohner, H.4
Stilgenbauer, S.5
Lichter, P.6
-
15
-
-
0035194847
-
Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis
-
Gamberale R, Geffner J, Arrosagaray G, Scolnik M, Salamone G, Trevani A et al. Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis. Leukemia 2001; 15: 1860-1867. (Pubitemid 33114992)
-
(2001)
Leukemia
, vol.15
, Issue.12
, pp. 1860-1867
-
-
Gamberale, R.1
Geffner, J.2
Arrosagaray, G.3
Scolnik, M.4
Salamone, G.5
Trevani, A.6
Vermeulen, M.7
Giordano, M.8
-
16
-
-
66149112944
-
Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow
-
Hartmann TN, Grabovsky V, Wang W, Desch P, Rubenzer G, Wollner S et al. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow. Cancer Res 2009; 69: 3121-3130.
-
(2009)
Cancer Res
, vol.69
, pp. 3121-3130
-
-
Hartmann, T.N.1
Grabovsky, V.2
Wang, W.3
Desch, P.4
Rubenzer, G.5
Wollner, S.6
-
17
-
-
23944488816
-
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
-
DOI 10.1182/blood-2004-12-4918
-
Burger M, Hartmann T, Krome M, Rawluk J, Tamamura H, Fujii N et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 2005; 106: 1824-1830. (Pubitemid 41208600)
-
(2005)
Blood
, vol.106
, Issue.5
, pp. 1824-1830
-
-
Burger, M.1
Hartmann, T.2
Krome, M.3
Rawluk, J.4
Tamamura, H.5
Fujii, N.6
Kipps, T.J.7
Burger, J.A.8
-
18
-
-
84874885773
-
The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of b-lymphocyte migration
-
Kaucka M, Plevova K, Pavlova S, Janovska P, Mishra A, Verner J et al. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of b-lymphocyte migration. Cancer Res 2013; 73: 1491-1501.
-
(2013)
Cancer Res
, vol.73
, pp. 1491-1501
-
-
Kaucka, M.1
Plevova, K.2
Pavlova, S.3
Janovska, P.4
Mishra, A.5
Verner, J.6
-
19
-
-
84861209840
-
RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans
-
Troeger A, Johnson AJ, Wood J, Blum WG, Andritsos LA, Byrd JC et al. RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans. Blood 2012; 119: 4708-4718.
-
(2012)
Blood
, vol.119
, pp. 4708-4718
-
-
Troeger, A.1
Johnson, A.J.2
Wood, J.3
Blum, W.G.4
Andritsos, L.A.5
Byrd, J.C.6
-
20
-
-
58249100053
-
CXCR4 antagonists: Targeting the microenvironment in leukemia and other cancers
-
Burger JA, Peled A. CXCR4 antagonists: Targeting the microenvironment in leukemia and other cancers. Leukemia 2008; 23: 43-52.
-
(2008)
Leukemia
, vol.23
, pp. 43-52
-
-
Burger, J.A.1
Peled, A.2
-
21
-
-
84878411869
-
Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment
-
Schulz A, Du rr C, Zenz T, Do hner H, Stilgenbauer S, Lichter P et al. Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment. Blood 2013; 121: 2503-2511.
-
(2013)
Blood
, vol.121
, pp. 2503-2511
-
-
Schulz, A.1
Durr, C.2
Zenz, T.3
Dohner, H.4
Stilgenbauer, S.5
Lichter, P.6
-
22
-
-
34548138924
-
Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids
-
Seiffert M, Stilgenbauer S, Do hner H, Lichter P. Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids. Leukemia 2007; 21: 1977-1983.
-
(2007)
Leukemia
, vol.21
, pp. 1977-1983
-
-
Seiffert, M.1
Stilgenbauer, S.2
Dohner, H.3
Lichter, P.4
-
23
-
-
34447116953
-
Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen
-
DOI 10.1158/0008-5472.CAN-07-0663
-
Rebacz B, Larsen TO, Clausen MH, Ronnest MH, Loffler H, Ho AD et al. Identification of Griseofulvin as an Inhibitor of Centrosomal Clustering in a Phenotype-Based Screen. Cancer Res 2007; 67: 6342-6350. (Pubitemid 47037517)
-
(2007)
Cancer Research
, vol.67
, Issue.13
, pp. 6342-6350
-
-
Rebacz, B.1
Larsen, T.O.2
Clausen, M.H.3
Ronnest, M.H.4
Loffler, H.5
Ho, A.D.6
Kramer, A.7
-
24
-
-
66249107708
-
Synthesis and structure-Activity relationship of griseofulvin analogues as inhibitors of centrosomal clustering in cancer cells
-
Rñest MH, Rebacz B, Markworth L, Terp AH, Larsen TO, Kramer A et al. Synthesis and Structure-Activity Relationship of Griseofulvin Analogues as Inhibitors of Centrosomal Clustering in Cancer Cells. J Med Chem 2009; 52: 3342-3347.
-
(2009)
J Med Chem
, vol.52
, pp. 3342-3347
-
-
Rñest, M.H.1
Rebacz, B.2
Markworth, L.3
Terp, A.H.4
Larsen, T.O.5
Kramer, A.6
-
25
-
-
79952320233
-
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: A dominant role of CCL2
-
Schulz A, Toedt G, Zenz T, Stilgenbauer S, Lichter P, Seiffert M. Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: A dominant role of CCL2. Haematologica 2011; 96: 408-416.
-
(2011)
Haematologica
, vol.96
, pp. 408-416
-
-
Schulz, A.1
Toedt, G.2
Zenz, T.3
Stilgenbauer, S.4
Lichter, P.5
Seiffert, M.6
-
26
-
-
0033485625
-
Chronic lymphocytic leukemia b cells express functional cxcr4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells
-
Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia b cells express functional cxcr4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999; 94: 3658-3667.
-
(1999)
Blood
, vol.94
, pp. 3658-3667
-
-
Burger, J.A.1
Burger, M.2
Kipps, T.J.3
-
27
-
-
29344444077
-
Phenotypic taxonomy and metabolite profiling in microbial drug discovery
-
DOI 10.1039/b404943h
-
Larsen TO, Smedsgaard J, Nielsen KF, Hansen ME, Frisvad JC. Phenotypic taxonomy and metabolite profiling in microbial drug discovery. Nat Prod Rep 2005; 22: 672-695. (Pubitemid 43000329)
-
(2005)
Natural Product Reports
, vol.22
, Issue.6
, pp. 672-695
-
-
Larsen, T.O.1
Smedsgaard, J.2
Nielsen, K.F.3
Hansen, M.E.4
Frisvad, J.C.5
-
28
-
-
84890946411
-
Bio-Activity and dereplication based discovery of ophiobolins and other fungal secondary metabolites targeting leukemia cells
-
Bladt TT, Du rr C, Knudsen PB, Kildgaard S, Frisvad JC, Gotfredsen CH et al. Bio-Activity and dereplication based discovery of ophiobolins and other fungal secondary metabolites targeting leukemia cells. Molecules 2013; 18: 14629-14650.
-
(2013)
Molecules
, vol.18
, pp. 14629-14650
-
-
Bladt, T.T.1
Durr, C.2
Knudsen, P.B.3
Kildgaard, S.4
Frisvad, J.C.5
Gotfredsen, C.H.6
-
30
-
-
0019941269
-
Chaetoglobosins, cytotoxic 10-(indol-3-yl)-[13] cytochalasans from chaetomium spp I Production, isolation and some cytological effects of chaetoglobosins A-J
-
Sekita S, Yoshihira K, Natori S, Udagawa S, Sakabe F, Kurata H et al. Chaetoglobosins, cytotoxic 10-(indol-3-yl)-[13] cytochalasans from chaetomium spp. I. Production, isolation and some cytological effects of chaetoglobosins A-J. Chem Pharm Bull 1982; 30: 1609-1617.
-
(1982)
Chem Pharm Bull
, vol.30
, pp. 1609-1617
-
-
Sekita, S.1
Yoshihira, K.2
Natori, S.3
Udagawa, S.4
Sakabe, F.5
Kurata, H.6
-
31
-
-
84875456366
-
A Combination of cytokines rescues highly purified leukemic cll b-cells from spontaneous apoptosis
-
Ghamlouch H, Ouled-Haddou H, Damaj G, Royer B, Gubler B, Marolleau J-P. A Combination of cytokines rescues highly purified leukemic cll b-cells from spontaneous apoptosis. PLoS One 2013; 8: E60370.
-
(2013)
PLoS One
, vol.8
-
-
Ghamlouch, H.1
Ouled-Haddou, H.2
Damaj, G.3
Royer, B.4
Gubler, B.5
Marolleau, J.-P.6
-
32
-
-
0020029505
-
Correlation between effects of different cytochalasins on cellular structures and cellular events and those on actin in vitro
-
Yahara I, Harada F, Sekita S, Yoshihira K, Natori S. Correlation between effects of different cytochalasins on cellular structures and cellular events and those on actin in vitro. J Cell Biol 1982; 92: 69-78.
-
(1982)
J Cell Biol
, vol.92
, pp. 69-78
-
-
Yahara, I.1
Harada, F.2
Sekita, S.3
Yoshihira, K.4
Natori, S.5
-
33
-
-
78751549662
-
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia
-
Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2010; 117: 563-574.
-
(2010)
Blood
, vol.117
, pp. 563-574
-
-
Herishanu, Y.1
Perez-Galan, P.2
Liu, D.3
Biancotto, A.4
Pittaluga, S.5
Vire, B.6
-
34
-
-
36349025291
-
Clonal evolution in chronic lymphocytic leukemia: Acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival
-
DOI 10.3324/haematol.10720
-
Stilgenbauer S, Sander S, Bullinger L, Benner A, Leupolt E, Winkler D et al. Clonal evolution in chronic lymphocytic leukemia: Acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007; 92: 1242-1245. (Pubitemid 350144184)
-
(2007)
Haematologica
, vol.92
, Issue.9
, pp. 1242-1245
-
-
Stilgenbauer, S.1
Sander, S.2
Bullinger, L.3
Benner, A.4
Leupolt, E.5
Winkler, D.6
Krober, A.7
Kienle, D.8
Lichter, P.9
Dohner, H.10
-
35
-
-
84869753284
-
Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns
-
Schuh A, Becq J, Humphray S, Alexa A, Burns A, Clifford R et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 2012; 120: 4191-4196.
-
(2012)
Blood
, vol.120
, pp. 4191-4196
-
-
Schuh, A.1
Becq, J.2
Humphray, S.3
Alexa, A.4
Burns, A.5
Clifford, R.6
-
36
-
-
84874102335
-
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
-
Landau D, Carter S, Stojanov P, McKenna A, Stevenson K, Lawrence M et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013; 152: 714-726.
-
(2013)
Cell
, vol.152
, pp. 714-726
-
-
Landau, D.1
Carter, S.2
Stojanov, P.3
McKenna, A.4
Stevenson, K.5
Lawrence, M.6
-
38
-
-
0022994763
-
Effects of chaetoglobosin J on the G-F transformation of actin
-
DOI 10.1016/0167-4838(86)90110-X
-
Maruyama K, Oosawa M, Tashiro A, Suzuki T, Tanikawa M, Kikuchi M et al. Effects of chaetoglobosin J on the G-F transformation of actin. Biochim Biophys Acta (BBA) 1986; 874: 137-143. (Pubitemid 17181086)
-
(1986)
Biochimica et Biophysica Acta-Protein Structure and Molecular Enzymology
, vol.874
, Issue.2
, pp. 137-143
-
-
Maruyama, K.1
Oosawa, M.2
Tashiro, A.3
-
39
-
-
0035253753
-
Cytoskeletal changes in cell transformation and tumorigenesis
-
DOI 10.1016/S0959-437X(00)00154-4
-
Pawlak G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Opin Genet Dev 2001; 11: 41-47. (Pubitemid 32119276)
-
(2001)
Current Opinion in Genetics and Development
, vol.11
, Issue.1
, pp. 41-47
-
-
Pawlak, G.1
Helfman, D.M.2
-
41
-
-
0033925380
-
Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth
-
Udagawa T, Yuan J, Panigrahy D, Chang Y-H, Shah J, D'Amato RJ et al. an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. J Pharmacol Exp Ther 2000; 294: 421-427. (Pubitemid 30490811)
-
(2000)
Journal of Pharmacology and Experimental Therapeutics
, vol.294
, Issue.2
, pp. 421-427
-
-
Udagawa, T.1
Yuan, J.2
Panigrahy, D.3
Chang, Y.-H.4
Shah, J.5
D'Amato, R.J.6
-
42
-
-
0031786517
-
Antiproliferative and cytotoxic effects of geldanamycin, cytochalasin E, suramin and thiacetazone in human prostate xenograft tumor histocultures
-
DOI 10.1023/A:1011921031564
-
Gan Y, Au JS, Lu J, Wientjes MG. Antiproliferative and cytotoxic effects of geldanamycin, cytochalasin e, suramin and thiacetazone in human prostate xenograft tumor histocultures. Pharm Res 1998; 15: 1760-1766. (Pubitemid 28524589)
-
(1998)
Pharmaceutical Research
, vol.15
, Issue.11
, pp. 1760-1766
-
-
Gan, Y.1
Au, J.L.-S.2
Lu, J.3
Wientjes, M.G.4
-
43
-
-
79955804759
-
In Vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells
-
Van Goietsenoven G, Mathieu V, Andolfi A, Cimmino A, Lefranc F, Kiss R et al. In Vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells. Planta Med 2011; 77: 711-717.
-
(2011)
Planta Med
, vol.77
, pp. 711-717
-
-
Van Goietsenoven, G.1
Mathieu, V.2
Andolfi, A.3
Cimmino, A.4
Lefranc, F.5
Kiss, R.6
-
44
-
-
0025268208
-
Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma
-
Bousquet PF, Paulsen LA, Fondy C, Lipski KM, Loucy KJ, Fondy TP. Effects of cytochalasin b in culture and in vivo on murine madison 109 lung carcinoma and on b16 melanoma. Cancer Res 1990; 50: 1431-1439. (Pubitemid 20090451)
-
(1990)
Cancer Research
, vol.50
, Issue.5
, pp. 1431-1439
-
-
Bousquet, P.F.1
Paulsen, L.A.2
Fondy, C.3
Lipski, K.M.4
Loucy, K.J.5
Fondy, T.P.6
-
45
-
-
0030921944
-
Phomacins: Three novel antitumor cytochalasan constituents produced by a phoma sp
-
Alvi KA, Nair B, Pu H, Ursino R, Gallo C, Mocek U. Phomacins: Three novel antitumor cytochalasan constituents produced by a phoma sp. J Org Chem1997; 62: 2148-2151.
-
(1997)
J Org Chem
, vol.62
, pp. 2148-2151
-
-
Alvi, K.A.1
Nair, B.2
Pu, H.3
Ursino, R.4
Gallo, C.5
Mocek, U.6
-
46
-
-
33646773191
-
Specialisation of the tropomyosin composition of actin filaments provides new potential targets for chemotherapy
-
DOI 10.2174/156800906776842948
-
Stehn JR, Schevzov G, ONeill GM, Gunning PW. Specialisation of the tropomyosin composition of actin filaments provides new potential targets for chemotherapy. Curr Cancer Drug Targets 2006; 6: 245-256. (Pubitemid 43764743)
-
(2006)
Current Cancer Drug Targets
, vol.6
, Issue.3
, pp. 245-256
-
-
Stehn, J.R.1
Schevzov, G.2
Oneill, G.M.3
Gunning, P.W.4
-
47
-
-
84865483514
-
The antitumour activities induced by pegylated liposomal cytochalasin D in murine models
-
Huang F-y, Mei W-l, Li Y-n Tan G-h, Dai H-f, Guo J-l et al. The antitumour activities induced by pegylated liposomal cytochalasin D in murine models. Eur J Cancer 2012; 48: 2260-2269.
-
(2012)
Eur J Cancer
, vol.48
, pp. 2260-2269
-
-
Huang, F.-Y.1
Mei, W.-L.2
Li, Y.-N.3
Tan, G.-H.4
Dai, H.-F.5
Guo, J.-L.6
-
48
-
-
64649084194
-
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia
-
Nowakowski GS, Hoyer JD, Shanafelt TD, Zent CS, Call TG, Bone ND et al. Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia. J Clin Oncol 2009; 27: 1844-1849.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1844-1849
-
-
Nowakowski, G.S.1
Hoyer, J.D.2
Shanafelt, T.D.3
Zent, C.S.4
Call, T.G.5
Bone, N.D.6
-
49
-
-
77952957320
-
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia
-
Johansson P, Eisele L, Klein-Hitpass L, Sellmann L, Du hrsen U, Du rig J et al. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia. Leuk Res 2010; 34: 892-898.
-
(2010)
Leuk Res
, vol.34
, pp. 892-898
-
-
Johansson, P.1
Eisele, L.2
Klein-Hitpass, L.3
Sellmann, L.4
Du Hrsen, U.5
Du Rig, J.6
-
50
-
-
34249682108
-
Novel functions of vimentin in cell adhesion, migration, and signaling
-
DOI 10.1016/j.yexcr.2007.03.040, PII S0014482707001450
-
Ivaska J, Pallari H-M, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration and signaling. Exp Cell Res 2007; 313: 2050-2062. (Pubitemid 46842979)
-
(2007)
Experimental Cell Research
, vol.313
, Issue.10
, pp. 2050-2062
-
-
Ivaska, J.1
Pallari, H.-M.2
Nevo, J.3
Eriksson, J.E.4
-
51
-
-
0020079283
-
Decreased actin content of lymphocytes from patients with chronic lymphocytic leukemia
-
Stark R, Liebes L, Nevrla D, Conklyn M, Silber R. Decreased actin content of lymphocytes from patients with chronic lymphocytic leukemia. Blood 1982; 59: 536-541. (Pubitemid 12187471)
-
(1982)
Blood
, vol.59
, Issue.3
, pp. 536-541
-
-
Stark, R.1
Liebes, L.F.2
Nevrla, D.3
-
52
-
-
77955444557
-
How the microenvironment shapes chronic lymphocytic leukemia: The cytoskeleton connection
-
Scielzo C, Hacken ET, Bertilaccio MTS, Muzio M, Calissano C, Ghia P et al. How the microenvironment shapes chronic lymphocytic leukemia: The cytoskeleton connection. Leuk Lymphoma 2010; 51: 1371-1374.
-
(2010)
Leuk Lymphoma
, vol.51
, pp. 1371-1374
-
-
Scielzo, C.1
Hacken, E.T.2
Bertilaccio, M.T.S.3
Muzio, M.4
Calissano, C.5
Ghia, P.6
-
53
-
-
84877930233
-
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia
-
ten Hacken E, Scielzo C, Bertilaccio MTS, Scarfo L, Apollonio B, Barbaglio F et al. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia. Blood 2013; 121: 2264-2273.
-
(2013)
Blood
, vol.121
, pp. 2264-2273
-
-
Ten Hacken, E.1
Scielzo, C.2
Bertilaccio, M.T.S.3
Scarfo, L.4
Apollonio, B.5
Barbaglio, F.6
-
54
-
-
78149309123
-
HS1 has a central role in the trafficking and homing of leukemic b cells
-
Scielzo C, Bertilaccio MTS, Simonetti G, Dagklis A, ten Hacken E, Fazi C et al. HS1 has a central role in the trafficking and homing of leukemic B cells. Blood 2010; 116: 3537-3546.
-
(2010)
Blood
, vol.116
, pp. 3537-3546
-
-
Scielzo, C.1
Bertilaccio, M.T.S.2
Simonetti, G.3
Dagklis, A.4
Ten Hacken, E.5
Fazi, C.6
-
55
-
-
76949108167
-
The membrane skeleton controls diffusion dynamics and signaling through the B-cell receptor
-
Treanor B, Depoil D, Gonzalez-Granja A, Barral P, Weber M, Dushek O et al. The membrane skeleton controls diffusion dynamics and signaling through the B-cell receptor. Immunity 2010; 32: 187-199.
-
(2010)
Immunity
, vol.32
, pp. 187-199
-
-
Treanor, B.1
Depoil, D.2
Gonzalez-Granja, A.3
Barral, P.4
Weber, M.5
Dushek, O.6
-
56
-
-
84863781222
-
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration
-
Hoellenriegel J, Coffey GP, Sinha U, Pandey A, Sivina M, Ferrajoli A et al. Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration. Leukemia 2012; 26: 1576-1583.
-
(2012)
Leukemia
, vol.26
, pp. 1576-1583
-
-
Hoellenriegel, J.1
Coffey, G.P.2
Sinha, U.3
Pandey, A.4
Sivina, M.5
Ferrajoli, A.6
-
57
-
-
84858636448
-
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor-And chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
-
de Rooij MFM, Kuil A, Geest CR, Eldering E, Chang BY, Buggy JJ et al. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor-And chemokine-controlled adhesion and migration in chronic lymphocytic leukemia. Blood 2012; 119: 2590-2594.
-
(2012)
Blood
, vol.119
, pp. 2590-2594
-
-
De Rooij, M.F.M.1
Kuil, A.2
Geest, C.R.3
Eldering, E.4
Chang, B.Y.5
Buggy, J.J.6
-
58
-
-
80053345977
-
The phosphoinositide 30-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
-
Hoellenriegel J, Meadows SA, Sivina M, Wierda WG, Kantarjian H, Keating MJ et al. The phosphoinositide 30-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood 2011; 118: 3603-3612.
-
(2011)
Blood
, vol.118
, pp. 3603-3612
-
-
Hoellenriegel, J.1
Meadows, S.A.2
Sivina, M.3
Wierda, W.G.4
Kantarjian, H.5
Keating, M.J.6
-
59
-
-
0017872126
-
Acute toxic effects of chaetoglobosin A, a new cytochalasan compound produced by Chaetomium globosum, on mice and rats
-
Ohtsubo K SM, Sekita S, Yoshihira K, Natori S. Acute toxic effects of chaetoglobosin A, a new cytochalasan compound produced by Chaetomium globosum, on mice and rats. Jpn J Exp Med 1978; 48: 105-110. (Pubitemid 8367579)
-
(1978)
Japanese Journal of Experimental Medicine
, vol.48
, Issue.2
, pp. 105-110
-
-
Ohtsubo, K.1
Saito, M.2
Sekita, S.3
|